Vaccine research is a dynamic field focused on understanding, developing, and optimizing vaccines to prevent infectious diseases. The process involves multidisciplinary collaboration between immunologists, virologists, geneticists, and other experts. Research begins with identifying suitable antigens, often proteins or genetic material, from pathogens. Various vaccine platforms, including live attenuated, inactivated, subunit, and mRNA vaccines, are explored to elicit robust immune responses. Preclinical studies involve testing vaccine candidates in animals to assess safety, immunogenicity, and efficacy. Promising candidates progress to clinical trials, where they undergo rigorous testing in human volunteers to evaluate safety, dosage, and effectiveness. Advancements in vaccinology also involve exploring novel adjuvants, delivery methods, and formulations to enhance immune responses and improve vaccine stability. The emergence of new infectious threats, such as the COVID-19 pandemic, highlights the agility and innovation required in vaccine research. Collaborative efforts between academia, industry, and public health organizations continue to drive progress, ensuring the development of safe and effective vaccines to address global health challenges. Ongoing research efforts aim to broaden vaccine applicability, enhance durability, and optimize strategies for equitable global distribution.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia